UK markets closed

IDEXX Laboratories, Inc. (IDXX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
651.14+5.90 (+0.91%)
As of 12:38PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
3,046,576
2,706,655
2,406,908
2,213,242
1,969,058
Cost of revenue
1,254,378
1,135,615
1,041,359
971,700
871,676
Gross profit
1,792,198
1,571,040
1,365,549
1,241,542
1,097,382
Operating expenses
Research development
151,570
141,249
133,193
117,863
109,182
Selling general and administrative
776,802
735,267
679,510
632,344
575,172
Total operating expenses
928,372
876,516
812,703
750,207
684,354
Operating income or loss
863,826
694,524
552,846
491,335
413,028
Interest expense
31,135
33,125
31,055
34,744
37,225
Income before tax
833,211
661,985
522,218
457,742
381,057
Income tax expense
105,037
79,854
94,426
80,695
117,788
Income from continuing operations
728,174
582,131
427,792
377,047
263,269
Net income
727,848
581,776
427,720
377,031
263,144
Net income available to common shareholders
727,848
581,776
427,720
377,031
263,144
Basic EPS
-
6.82
4.97
4.34
3.00
Diluted EPS
-
6.71
4.89
4.26
2.94
Basic average shares
-
85,342
86,115
86,864
87,769
Diluted average shares
-
86,722
87,542
88,470
89,567
EBITDA
-
791,108
641,284
575,664
501,422